Congratulations Dr. Zanwar on many recent accomplishments!! Dr. Zanwar was recently awarded the Mayo Brothers Distinguished Fellowship Award in addition to obtaining a Hematology Small Grant and Merit Award. We are amazed by all you do! Saurabh Zanwar

Phenomenal lecture by Dr. Al-Kali on relapsed refractory AML this morning. A very complex topic condensed into understandable and practical treatment considerations. Thank you Aref Al-Kali #MedEd

Excellent grand rounds given by our very own Dr Pritchett whose hard work is bringing health care closer to the patients 👏🏻 Joshua Pritchett, MD

Congratulations to our former students and future collaborators!! Your hard work and dedication have truly paid off. Wishing you continued success in all your future endeavors! University of Minnesota MD-PhD Program

We are SO EXCITED to welcome our incoming PGY1 categorical and prelim residents to Mayo Clinic!!! Congratulations and we can’t wait to see you in June!!! 🥳🤩😍🎉 Carrie Thompson, MD Alessandra Tomasi Chris Heinrich M.D. Benjamin Stultz, MD Sara Bonnes, M.D., M.S. Chris Stephenson, MD, MHPE Alice Gallo, MD Sahil Khanna, MBBS, MS, FACG, AGAF (he/him)

Hard to find the words to convey the significance of this. What an immense privilege and opportunity to share our journey of design, implementation, and impact of this program through the NEJM Catalyst platform. Thanks to Mayo Clinic Comprehensive Cancer Center Mayo Clinic Mayo Clinic Internal Medicine Residency Rochester Mayo Clinic Hematology-Oncology Fellowship

Our fellows presenting their projects at #ASCO24! Antonious Z. Hazim, MD Richard Godby

A few more highlights from Mayo fellows at #ASCO24! Arthi Sridhar @Aditisinghlove

haematologica.org/article/view/h… #CMML Molecular pathobiology and therapeutic vulnerabilities Ludovica Marando, MD, PhD Clifford Csizmar #ASXL1 #RAS Mayo Clinic Comprehensive Cancer Center Haematologica

Are you interested in understanding how #RAS mutations could be targeted in #CMML please read our review in Haematologica by Ludovica Marando, MD, PhD and Clifford Csizmar #KRAS #NRAS #SHP2 #PLK1 #WEE1 Mayo Clinic Comprehensive Cancer Center

Out now! Our work showing that ASXL1/TET2 co-mutation status enhances risk-stratification in CMML independent of VAF. Grateful to Mrinal Patnaik for the mentorship and to Guillermo Montalban-Bravo and Eric Padron MD for the collaboration! haematologica.org/article/view/h…

Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matche… pubmed.ncbi.nlm.nih.gov/39533069/ Guillermo Montalban-Bravo Doug Tremblay Clifford Csizmar Eric Padron MD #CMML #Venetoclax

Out now! Our institutional series of DEK::NUP214 rearranged AML showing favorable outcomes post-HCT. FLT3 inhibitors may help get there. Grateful to Aref Al-Kali and Dr. Scott Kaufmann for the mentorship! haematologica.org/article/view/h…

A new hope for our patients with MLL/KMT2A positive rr#Acute_leukemia ❤️ 💊

Happy #ManuscriptMonday featuring a publication by PGY2 Dr. Tessier!! Carrie Thompson, MD ✨📚

It’s been an incredible few days at #ASH24, here are some of our second year fellows representing their work! Savannah Liddell M.D. Clifford Csizmar Syeda Mina

Congratulations to Dr. Tomasi Alessandra Tomasi on being appointed as the chief nephrology fellow for the academic year 2025-2026.

A bit late, but our review of Antibody-Based and Other Novel Agents in Adult B-ALL is out! Many thanks to Drs. Saliba and Litzow Mark Litzow for their expertise! mdpi.com/3197744

Landscape and clinicopathologic features of RAS pathway mutations in chronic myelomonocytic leukemia - PubMed ⁦MD Anderson Cancer Center⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩ ⁦Blood Journals Portfolio⁩ GMB ⁦Sanam Loghavi, MD صنم لغوی 🔬🧬⁩ ⁦Naveen Pemmaraju, MD⁩ ⁦Clifford Csizmar⁩ #CMML #RAS pubmed.ncbi.nlm.nih.gov/40644618/

When it comes to TET2 mutations in CMML, more are better! Multiple TET2 mt offset the negative impacts of ASXL1 and RAS mutations in myelodysplastic and myeloproliferative CMML, respectively. Mrinal Patnaik nature.com/articles/s4137…